Vivani Medical, Inc. Logo

Vivani Medical, Inc.

Develops long-term subdermal drug implants for chronic diseases like diabetes & weight management.

VANI | US

Overview

Corporate Details

ISIN(s):
US81362J2096 (+1 more)
LEI:
Country:
United States of America
Address:
1350 S. LOOP ROAD, 94502 ALAMEDA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company developing novel, long-term drug implant solutions for chronic diseases. The company's proprietary NanoPortal™ platform technology enables the creation of miniature, subdermal implants designed to provide steady, continuous drug delivery for six months to a year or longer. This approach aims to solve major treatment challenges, including medication non-adherence and tolerability issues associated with fluctuating drug levels. Vivani's lead pipeline candidates include NPM-139, a semaglutide implant for chronic weight management, and NPM-133, a semaglutide implant for type 2 diabetes. The implants are administered via a simple outpatient procedure, seeking to replace frequent self-injections and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Vivani Medical, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vivani Medical, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vivani Medical, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland
PHR
Bulgaria
PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea
005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands
PHARM
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel
PMCN-M
Pharvaris N.V. Logo
Developing oral therapies for rare angioedema to treat and prevent attacks.
United States of America
PHVS
Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America
PHAT
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France
ALPHE
PHIBRO ANIMAL HEALTH CORP Logo
Develops animal health products, vaccines, and nutrition for livestock and companion animals.
United States of America
PAHC
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy
PHIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.